id: neuroinflammation_myoinositol_to_neurodevelopmental_impairment_risk
name: Neuroinflammation (Elevated Myo-Inositol) â†’ Neurodevelopmental Impairment Risk
from_node:
  node_id: neuroinflammation_myoinositol
  node_name: Neuroinflammation (Elevated Myo-Inositol)
to_node:
  node_id: neurodevelopmental_impairment_risk
  node_name: Neurodevelopmental Impairment Risk
direction: positive
category: biological
mechanism_pathway:
- 'Step 1: Elevated myo-inositol indicates ongoing glial reactivity and neuroinflammatory
  processes in developing brain'
- 'Step 2: Neuroinflammation disrupts normal white matter maturation and myelination
  processes critical for cognitive development'
- 'Step 3: White matter alterations impair neural connectivity and information processing
  speed'
- 'Step 4: Disrupted brain development manifests as impaired neurodevelopment during
  first years of life'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: 'Cesc Bertran-Cobo et al. 2022. "A Neurometabolic Pattern of Elevated
    Myo-Inositol in Children Who Are HIV-Exposed and Uninfected: A South African Birth
    Cohort Study.." *Frontiers in immunology*. https://doi.org/10.3389/fimmu.2022.800273'
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:07.002082'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
